Details
Stereochemistry | RACEMIC |
Molecular Formula | C22H31NO3 |
Molecular Weight | 357.4864 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)C2=CC=CC=C2
InChI
InChIKey=XIQVNETUBQGFHX-UHFFFAOYSA-N
InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3
Molecular Formula | C22H31NO3 |
Molecular Weight | 357.4864 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 18:50:26 UTC 2023
by
admin
on
Fri Dec 15 18:50:26 UTC 2023
|
Record UNII |
K9P6MC7092
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NDF-RT |
N0000000125
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
WHO-ATC |
G04BD04
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
NDF-RT |
N0000000125
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
LIVERTOX |
NBK548652
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
NDF-RT |
N0000000125
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
NDF-RT |
N0000175700
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
KENTERA (AUTHORIZED: URINARY INCONTINENCE, URGE)
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
WHO-VATC |
QG04BD04
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
||
|
NCI_THESAURUS |
C29704
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8324
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB09558MIG
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
DTXSID0023406
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
K9P6MC7092
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
3270
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
4634
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
7856
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
K9P6MC7092
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
5633-20-5
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
Oxybutinyn
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
DB01062
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
359
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
C47647
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
100000085472
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
OXYBUTYNIN
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
NN-54
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
1354
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
C005419
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
CHEMBL1231
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
2028
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | |||
|
32675
Created by
admin on Fri Dec 15 18:50:26 UTC 2023 , Edited by admin on Fri Dec 15 18:50:26 UTC 2023
|
PRIMARY | RxNorm |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
ENANTIOMER -> RACEMATE |
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
ACTIVE ENANTIOMER->RACEMATE |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE ACTIVE -> PARENT |
MAJOR
PLASMA; URINE
|
||
|
METABOLITE INACTIVE -> PARENT |
MAJOR
|
||
|
METABOLITE ACTIVE -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC PHARMACOKINETIC |
|
||
Biological Half-life | PHARMACOKINETIC |
|
|
|||
Volume of Distribution | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
Elimination PHARMACOKINETIC PHARMACOKINETIC |
|
||